Pain, Neurological Disorders, and Cerebrovascular Pathophysiology: Study Notes for Anatomy & Physiology

Pain: Pathways, Perception, and Types

Introduction to Pain

Pain is a complex sensory and emotional experience that serves as a protective mechanism, alerting the body to potential or actual tissue damage. Understanding pain involves exploring its pathways, perception, and the various types and mechanisms involved.

• Definition: According to the International Association for the Study of Pain, pain is "an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage."

• Role of Pain:

  • Motivates individuals to seek medical help.

  • Encourages behaviors that promote healing.

  • Acts as a conditioning stimulus to avoid further injury.

Pain vs. Nociception

Nociception refers to the neural processes of encoding and processing noxious (harmful) stimuli, while pain is the subjective perception and emotional response to these stimuli.

Nociception	Pain
Third-person perspective	First-person perspective
Stimulus-related	Perception-related
Sensory discrimination	Suffering

Pain Terminology

Understanding pain requires familiarity with key terms:

Term	Definition
Acute pain	Pain that lasts less than 3 months.
Allodynia	Pain due to a stimulus that does not normally provoke pain.
Analgesia	Absence of pain in response to a stimulus that would normally be painful.
Chronic pain	Pain that lasts longer than 3 months.
Hyperalgesia	An increased response to a stimulus that is normally painful.
Referred pain	Pain perceived as occurring in a region of the body topographically distinct from the region in which the source of pain is located.

Types of Pain

• Nociceptive pain: Results from actual or threatened damage to non-neural tissue and is due to the activation of nociceptors. Can be external (e.g., cut, burn) or internal (e.g., organ injury).

• Neuropathic pain: Caused by injury or disease of the nervous system (e.g., diabetic neuropathy, post-herpetic neuralgia).

• Psychogenic pain: Pain influenced by psychological factors, often without clear physical cause.

Classification by Duration and Response

Type	Features
Acute	Short duration, resolves with healing, responds to analgesics, mostly nociceptive.
Chronic (non-cancer)	Persists beyond healing, poor response to conventional analgesics, often neuropathic features.
Cancer	May persist for months, responds to many interventions, often mixed nociceptive and neuropathic features.

Pathways and Physiology of Pain

Nociceptors and Transmission

Nociceptors are specialized sensory receptors that detect noxious stimuli. They can be classified as:

• High-threshold mechanoreceptors: Activated by intense mechanical stimuli; transmit sharp, fast pain via myelinated fibers.

• Polymodal nociceptors: Respond to mechanical, chemical, and thermal stimuli; transmit dull, aching, or burning pain via unmyelinated fibers.

• Musculoskeletal and visceral nociceptors: Often unmyelinated, involved in deep, poorly localized pain.

Pain Pathways

• Receptor Level: Nociceptors detect harmful stimuli.

• Spinal Cord: First synapse occurs in the dorsal horn.

• Spinothalamic Tract: Second-order neurons ascend to the thalamus.

• Thalamocortical Neurons: Project to the somatosensory cortex for pain perception.

There are two main components of pain processing:

• Sensory-discriminative: Identifies location, intensity, and quality of pain.

• Affective-motivational: Emotional and behavioral response to pain.

Neuromodulation of Pain

Pain perception is modulated by various neurotransmitters and neuromodulators:

• Excitatory: Substance P, glutamate, somatostatin (enhance pain transmission).

• Inhibitory: GABA, glycine, serotonin, noradrenaline (suppress pain transmission).

• Endorphins: Endogenous opioids (e.g., beta-endorphins, enkephalins) bind to opioid receptors to reduce pain.

Clinical Manifestations and Assessment

• Pain threshold: The minimum intensity at which a stimulus is perceived as painful.

• Pain tolerance: The maximum level of pain a person is able to tolerate.

• Pain dominance: When pain overshadows other sensations or symptoms.

• Autonomic responses: Tachycardia, tachypnea, increased blood pressure, sweating, nausea, vomiting.

Pain Assessment (PQRSTU):

• Provocation/Palliation: What causes or relieves the pain?

• Quality: What does the pain feel like?

• Region/Radiation: Where is the pain? Does it spread?

• Severity: How severe is the pain?

• Timing: When did it start? How long does it last?

• Understanding: What does the patient think is causing the pain?

Treatment of Pain

• Mild pain: Paracetamol, non-opioid analgesics, adjuvants.

• Moderate pain: Opioids (e.g., codeine, tramadol) plus non-opioids.

• Severe pain: Strong opioids (e.g., morphine, fentanyl, methadone) plus adjuvants.

• Advance up the analgesic ladder if pain persists.

Pathophysiology of Pain

Peripheral Neuropathic Pain

• Mononeuropathy: Damage to a single nerve (e.g., carpal tunnel syndrome).

• Polyneuropathy: Damage to multiple nerves (e.g., diabetic neuropathy).

• Complex regional pain syndromes: Chronic pain usually affecting a limb after injury.

• Post-herpetic neuralgia: Persistent pain after shingles.

Central Pain Syndromes

• Result from damage to brain or spinal cord regions involved in pain processing.

Degenerative Disorders of the Nervous System

Parkinson's Disease

Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra of the basal nuclei.

• Onset typically after age 40; average diagnosis at 55-65 years.

• More common in males.

• Clinical manifestations:

  • Resting tremor ("pill-rolling"), rigidity, bradykinesia (slowness of movement).

  • Postural instability, difficulty speaking and swallowing.

  • Autonomic dysfunction: excessive sweating, salivation, orthostatic hypotension, constipation, impotence, poor temperature control.

  • Facial masking (expressionless face), monotone speech, cognitive dysfunction.

• Diagnosis: Clinical history, examination, imaging (SPECT), response to dopaminergic therapy.

• Treatment: Dopamine agonists (levodopa), group support, exercise, nutrition, botulinum toxin for dystonias, surgical interventions (deep brain stimulation, precise lesions), experimental therapies (stem cells).

Multiple Sclerosis (MS)

Multiple sclerosis is a chronic, progressive, inflammatory, autoimmune demyelinating disorder of the central nervous system (CNS), characterized by destruction of oligodendrocytes by T cells.

• Relapsing-remitting course is common.

• First signs: paresthesias, optic disturbances, abnormal sensations in extremities and face.

• Progressive loss of function leads to permanent disability, usually after 20+ years.

Symptom
Loss of coordination/clumsiness
Speech difficulties
Hand shaking/tremor
Loss of bladder/bowel control
Extreme fatigue
Sight impairments
Memory lapses
Vertigo
Weakness
Impaired sensation

• Diagnosis: Clinical and laboratory criteria (CSF analysis, MRI, visual evoked potentials).

• Treatment: Interferon, corticosteroids, antidepressants, supportive care, assistance with activities of daily living (ADLs).

Intracranial Pressure and Cerebrovascular Disorders

Monro-Kellie Hypothesis

The Monro-Kellie hypothesis states that the cranial vault is a fixed volume composed of brain tissue, blood, and cerebrospinal fluid (CSF). An increase in one component must be offset by a decrease in another to maintain normal intracranial pressure (ICP), typically 5–15 mmHg.

Increased Intracranial Pressure (ICP)

• Caused by increased volume of brain tissue, blood, or CSF.

• Leads to ischemia (reduced or interrupted blood flow) and potential brain damage.

Cerebrovascular Disorders

Cerebrovascular accidents (CVAs), or strokes, are classified by their underlying cause:

• Thrombotic stroke: Arterial occlusions from thrombi formed in brain arteries or intracranial vessels.

• Transient ischaemic attacks (TIAs): Brief episodes of neurological dysfunction due to temporary ischemia.

• Lacunar infarcts: Small vessel strokes.

• Embolic stroke: Fragments from a thrombus formed outside the brain travel to cerebral vessels.

• Haemorrhagic stroke: Bleeding within the brain (intracerebral) or in the subarachnoid space.

Evaluation and Treatment of Stroke

• Diagnosis: Patient history, CT scan, MRI, angiography, lumbar puncture, ABCD system for TIAs.

• Supportive care: Maintain cerebral perfusion.

• Thrombotic stroke: Thrombolysis (clot-busting drugs).

• Haemorrhagic stroke: Treat raised ICP, stop bleeding.

• Ongoing: Anticoagulants (warfarin, aspirin), risk factor modification, aggressive rehabilitation.

Risk Factors for Stroke

• Increasing age, male sex, race, family history.

• Hypertension, smoking, poorly controlled diabetes, carotid stenosis, sickle cell disease, hyperlipidaemia, atrial fibrillation.

Summary Table: Types of Stroke

Type	Cause	Main Features
Thrombotic	Local clot formation in cerebral arteries	Gradual onset, often preceded by TIAs
Embolic	Clot from elsewhere travels to brain	Sudden onset, often in younger patients
Haemorrhagic	Rupture of blood vessel in brain	Sudden severe headache, rapid deterioration

Additional info: Where content was fragmented or implied, standard academic context and definitions have been added for completeness and clarity.